Clinical Trial Update: SGB Reduces the Incidence and Severity of CSA-AKI [NA]

View source ↗

Summary

A clinical trial update reports that stellate ganglion block reduces the incidence and severity of cardiac surgery-associated acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery-associated Acute Kidney Injury

Drugs mentioned

• Stellate Ganglion Block

Snippet

Sponsor: Yangzhou University | Conditions: Stellate Ganglion Block | NA | Status: COMPLETED